These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2565749)

  • 41. Effects of haloperidol and clozapine on preprotachykinin-A messenger RNA, tachykinin tissue levels, release and neurokinin-1 receptors in the striato-nigral system.
    Humpel C; Knaus GA; Auer B; Knaus HG; Haring C; Theodorsson E; Saria A
    Synapse; 1990; 6(1):1-9. PubMed ID: 1697986
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sleep during acute dopamine D1 agonist SKF 38393 or D1 antagonist SCH 23390 administration in rats.
    Monti JM; Fernández M; Jantos H
    Neuropsychopharmacology; 1990 Jun; 3(3):153-62. PubMed ID: 2141985
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regional changes of striatal dopamine receptors following denervation by 6-hydroxydopamine and fetal mesencephalic grafts in the rat.
    Gagnon C; Bédard PJ; Rioux L; Gaudin D; Martinoli MG; Pelletier G; Di Paolo T
    Brain Res; 1991 Sep; 558(2):251-63. PubMed ID: 1838295
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Amisulpride the 'atypical' atypical antipsychotic--comparison to haloperidol, risperidone and clozapine.
    Natesan S; Reckless GE; Barlow KB; Nobrega JN; Kapur S
    Schizophr Res; 2008 Oct; 105(1-3):224-35. PubMed ID: 18710798
    [TBL] [Abstract][Full Text] [Related]  

  • 45. SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems.
    Iorio LC; Barnett A; Leitz FH; Houser VP; Korduba CA
    J Pharmacol Exp Ther; 1983 Aug; 226(2):462-8. PubMed ID: 6135795
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inactivation of D1 and D2 dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by neuroleptics.
    Meller E; Bohmaker K; Goldstein M; Friedhoff AJ
    J Pharmacol Exp Ther; 1985 Jun; 233(3):656-62. PubMed ID: 2861276
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acute thioridazine stimulates mesolimbic but not nigrostriatal dopamine release: demonstration by in vivo electrochemistry.
    Lane RF; Blaha CD
    Brain Res; 1987 Apr; 408(1-2):317-20. PubMed ID: 2439169
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Electrochemistry in vivo: monitoring dopamine release in the brain of the conscious, freely moving rat.
    Lane RF; Blaha CD; Hari SP
    Brain Res Bull; 1987 Jul; 19(1):19-27. PubMed ID: 3651839
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stimulation of D2-receptors in rat nucleus accumbens slices inhibits dopamine and acetylcholine release but not cyclic AMP formation.
    Stoof JC; Verheijden PF; Leysen JE
    Brain Res; 1987 Oct; 423(1-2):364-8. PubMed ID: 2823991
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of amfonelic acid to discriminate between classical and atypical neuroleptics and neurotensin: an in vivo voltammetric study.
    Rivest R; Jolicoeur FB; Marsden CA
    Brain Res; 1991 Mar; 544(1):86-93. PubMed ID: 1677303
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of antipsychotic drugs on 5-HT2 receptors in the medial prefrontal cortex: microiontophoretic studies.
    Ashby CR; Wang RY
    Brain Res; 1990 Jan; 506(2):346-8. PubMed ID: 1967969
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dopamine receptor-mediated spinal antinociception in the normal and haloperidol pretreated rat: effects of sulpiride and SCH 23390.
    Barasi S; Ben-Sreti MM; Clatworthy AL; Duggal KN; Gonzalez JP; Robertson J; Rooney KF; Sewell RD
    Br J Pharmacol; 1987 Jan; 90(1):15-22. PubMed ID: 3545350
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Investigation of striatal dopamine D2 receptor acquisition following prenatal neuroleptic exposure.
    Schmidt MH; Lee T
    Psychiatry Res; 1991 Mar; 36(3):319-28. PubMed ID: 1676523
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modulation of neuroleptic activity of 9,10-didehydro-N-methyl-(2-propynyl)-6-methyl-8-aminomethylergoline bimaleinate (LEK-8829) by D1 intrinsic activity in hemi-parkinsonian rats.
    Glavan G; Sket D; Zivin M
    Mol Pharmacol; 2002 Feb; 61(2):360-8. PubMed ID: 11809861
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Participation of an endogenous Ca++-blinding protein activator in the development of drug-induced supersensitivity of striatal dopamine receptors.
    Gnegy M; Uzunov P; Costa E
    J Pharmacol Exp Ther; 1977 Sep; 202(3):558-64. PubMed ID: 19618
    [No Abstract]   [Full Text] [Related]  

  • 56. Dopamine D2 receptors attenuate phosphatidylinositol 4,5-bisphosphate in synaptosomal membranes from rat neostriatum.
    von Euler G; von Euler A
    J Neurochem; 1991 Jan; 56(1):136-40. PubMed ID: 1846171
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Direct in vivo electrochemical monitoring of dopamine release in response to neuroleptic drugs.
    Blaha CD; Lane RF
    Eur J Pharmacol; 1984 Feb; 98(1):113-7. PubMed ID: 6143672
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acute and long-term amphetamine treatments alter extracellular ascorbate in neostriatum but not nucleus accumbens of freely moving rats.
    Yount SE; Kraft ME; Pierce RC; Langley PE; Rebec GV
    Life Sci; 1991; 49(17):1237-44. PubMed ID: 1943438
    [TBL] [Abstract][Full Text] [Related]  

  • 59. DA2/NT receptor balance in the mesostriatal and mesolimbocortical systems after chronic treatment with typical and atypical neuroleptic drugs.
    Giardino L; Calzà L; Piazza PV; Zanni M; Amato G
    Brain Res; 1990 Nov; 532(1-2):140-5. PubMed ID: 1980851
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Corticostriatal and thalamic regulation of amphetamine-induced ascorbate release in the neostriatum.
    Basse-Tomusk A; Rebec GV
    Pharmacol Biochem Behav; 1990 Jan; 35(1):55-60. PubMed ID: 2315370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.